REDUCTION IN MIGRAINE-ASSOCIATED BURDEN OVER 24 WEEKS OF TREATMENT WITH EPTINEZUMAB IN PATIENTS WITH CHRONIC MIGRAINE

McAllister, P; Kudrow, D; Cady, R; Hirman, J; Ettrup, A

VALUE IN HEALTH, 2022; 25 (7): S316